SC

Salim Chennamkulathil Poulose

Active Director Additional Director DIN 08272644
DIN 08272644 First appointment Nov 2018 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Nov 2018
Shareholding value •••• Premium profile

About Salim Chennamkulathil Poulose

Data last updated:

Salim Chennamkulathil Poulose is an Additional Director at Mythrii Smart Ventures Private Limited (since 2018), Managing Director at Sante Healthcare Private Limited (since 2020) and Designated Partner at Chennamkulathil Estates Llp (since 2018). The companies operate in Business Services, Chemicals and Real Estate and Construction. The 2 current companies with reported revenue have a combined latest revenue of ₹31.1 Lakh; the largest is Mythrii Smart Ventures Private Limited at ₹23.6 Lakh (FY 2023). Earlier, Salim Chennamkulathil Poulose was a Managing Director at Cochin Karunya Pharmaceuticals Private Limited (from 2020).

DIN 08272644
Primary Designation Additional Director
Industry Business Services
First Appointment 28 Nov 2018
Oldest Company Age 10 yrs
Largest company Mythrii Smart Ventures Private Limited · ₹23.6 Lakh (FY 2023)
Combined revenue ₹31.1 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director27 Dec 20182015₹23.6 Lakh (FY 2023)Active
Sante Healthcare Private Limited U24230KA2020PTC134000
Managing Director04 May 20202020₹7.6 Lakh (FY 2021)Active
Designated Partner28 Nov 20182018Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director24 Jul 20202020Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sante Healthcare Private Limited
Cochin Karunya Pharmaceuticals Private Limited
Mythrii Smart Ventures Private Limited
Chennamkulathil Estates Llp
Premium access

Shareholding and investment profile for Salim Chennamkulathil Poulose

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Salim Chennamkulathil Poulose

Salim Chennamkulathil Poulose currently holds 3 directorships: Mythrii Smart Ventures Private Limited (Additional Director, since 27 Dec 2018, revenue ₹23.6 Lakh (FY 2023)); Sante Healthcare Private Limited (Managing Director, since 04 May 2020, revenue ₹7.6 Lakh (FY 2021)); Chennamkulathil Estates Llp (Designated Partner, since 28 Nov 2018).

Salim Chennamkulathil Poulose was first appointed on 28 Nov 2018 as Designated Partner at Chennamkulathil Estates Llp. The most recent appointment on record is 24 Jul 2020 at Cochin Karunya Pharmaceuticals Private Limited.

The 2 current companies of Salim Chennamkulathil Poulose that report revenue have a combined latest revenue of ₹31.1 Lakh: Mythrii Smart Ventures Private Limited ₹23.6 Lakh (FY 2023); Sante Healthcare Private Limited ₹7.6 Lakh (FY 2021).

Salim Chennamkulathil Poulose held 1 earlier board appointment: Cochin Karunya Pharmaceuticals Private Limited (Managing Director, from 24 Jul 2020).

The current boards of Salim Chennamkulathil Poulose's companies include Ajay Boby Hormis (Mythrii Smart Ventures Private Limited), George Pynadan Josekuttan (Mythrii Smart Ventures Private Limited), Poovathum Kandy Sreenivasan (Mythrii Smart Ventures Private Limited), Samuel Thomas (Mythrii Smart Ventures Private Limited), Anil Manuel Anandasserry (Sante Healthcare Private Limited), Isac John (Sante Healthcare Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available